SARAH FITZPATRICK: Open Payments
NPI 1164062105 · OXFORD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$976 in 52 payments from 12 companies in 2025. Trend: 2023 $462 · 2024 $988 · 2025 $976
Food & beverage: $976
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $281 |
| PFIZER INC. | 12 | $216 |
| Novo Nordisk Inc | 5 | $100 |
| Exact Sciences Corporation | 4 | $71 |
| Lilly USA, LLC | 4 | $68 |
| Alkermes, Inc. | 2 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $54 |
| Kerecis Limited | 2 | $35 |
| Seqirus USA Inc | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $33 |
Products named: NURTEC ODT, AIRSUPRA, FARXIGA, BREZTRI, Wegovy, VIVITROL, PREVNAR 20, Kerendia.
Industry payments across MI — which companies pay providers there.
